Literature DB >> 6772690

Comparison of three methods for the estimation of plasma antithrombin.

D S McLellan, J D Devlin, G H Heyse-Moore, A Aronstam.   

Abstract

Plasma antithrombin levels were measured by clotting, immunological, and amidolytic methods on two groups of subjects: 20 normal individuals and nine patients studied serially post-operatively (hip replacement). The postoperative patients were observed for the emergence of deep-vein thrombosis using 125I-fibrinogen uptake measurements (FUT). The three methods gave similar ranges for the normal subjects, were reproducible (cv less than 5%), and detected early postoperative reduction of antithrombin levels. All three methods failed to show any significant differences in preoperative antithrombin levels between the positive and negative FUT groups. Correlation studies were performed on the pooled data from the normal and postoperative group (range 60-130% of normal; 100 samples). The best correlation (r = 0.75; P less than 0.01) was achieved with the chromogenic kit assay method versus the Mancini immunoassay technique. The thrombin agarose (total antithrombin) gel diffusion technique correlated less well with the chromogenic (r = 0.65; P less than 0.01) and Mancini immunoassay (r = 0.45; P less than 0.01) methods. It is concluded that the chromogenic kit method gives a rapid, reproducible, and specific measurement of antithrombin III. The thrombin agarose diffusion method, though not specific for antithrombin III, is a cheap and simple method to perform. The potential of the three methods for detecting the prethrombotic stage and early thrombosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772690      PMCID: PMC1146107          DOI: 10.1136/jcp.33.5.438

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  The assay of antithrombin using a synthetic chromogenic substrate for thrombin.

Authors:  M Blombäck; B Blombäck; P Olsson; L Svendsen
Journal:  Thromb Res       Date:  1974-11       Impact factor: 3.944

2.  Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.

Authors:  G Sas; G Blaskó; D Bánhegyi; J Jákó; L A Pálos
Journal:  Thromb Diath Haemorrh       Date:  1974-09-30

3.  Postoperative antithrombin. 3.

Authors:  M B Donati; K Vandenberghe; A Molla; M De Roo; M Verstraete
Journal:  Lancet       Date:  1973-03-31       Impact factor: 79.321

4.  Postoperative antithrombin-3 concentration.

Authors:  N Stathakis; A G Papayannis; C D Gardikas
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

5.  Major operations, hemostatic parameters and venous thrombosis.

Authors:  E Korvald; U Abildgaard; M K Fagerhol
Journal:  Thromb Res       Date:  1974-01       Impact factor: 3.944

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Antithrombin 3, antifactor Xa and heparin.

Authors:  R Biggs; K W Denson; N Akman; R Borrett; M Hadden
Journal:  Br J Haematol       Date:  1970-09       Impact factor: 6.998

8.  Heparin cofactor activity measured with an amidolytic method.

Authors:  O R Odegard; M Lie; U Abildgaard
Journal:  Thromb Res       Date:  1975-04       Impact factor: 3.944

9.  Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma.

Authors:  U Abildgaard; M K Fagerhol; O Egeberg
Journal:  Scand J Clin Lab Invest       Date:  1970-12       Impact factor: 1.713

10.  Evaluation of an amidolytic heparin cofactor assay method.

Authors:  O R Odegård
Journal:  Thromb Res       Date:  1975-08       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.